CN105238804A - Method for improving expression quantity of human metallothionein MT3 prokaryotic expression vector - Google Patents
Method for improving expression quantity of human metallothionein MT3 prokaryotic expression vector Download PDFInfo
- Publication number
- CN105238804A CN105238804A CN201510703939.9A CN201510703939A CN105238804A CN 105238804 A CN105238804 A CN 105238804A CN 201510703939 A CN201510703939 A CN 201510703939A CN 105238804 A CN105238804 A CN 105238804A
- Authority
- CN
- China
- Prior art keywords
- prokaryotic expression
- human metal
- codon optimized
- sequence
- metal thioalbumen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses a method for improving expression quantity of human metallothionein MT3 prokaryotic expression vector. The method comprises artificially synthesizing codon-optimizing MT3 DNA molecule, wherein the molecule also comprises DNA endonuclease recognition sequences NcoI, SpeI and NheI; constructing the DNA molecule to the NcoI/NheI clone region of pET28a(+); and then performing series recombination to enable the MT coding gene containing a ribosome combining region to be amplified to have four copies. The method is applicable to construction of all micromolecule polypeptide (no more than 100 amino acids) expression vectors, the whole process is simple and rapid in operation, the prepared prokaryotic expression vector is improved in MT3 protein expression quantity, the cost is reduced, and the working efficiency is improved.
Description
Technical field
The invention belongs to genetically engineered field, particularly relate to a kind of method improving human metal thioalbumen MT3 prokaryotic expression carrier expression amount.
Background technology
Metallothionein(MT) (Metallothionein, MT), also known as sulfydryl metal binding protein., except the MT containing cadmium (Cd), zinc (Zn), also there is the MT containing copper (Cu), mercury (Hz), element such as gold (Au), bismuth (Bi) etc. at nature in one class non-enzymatic protein.Not containing die aromatischen Aminosaeuren and Histidine in the protein molecular of MT.The pH value allowing in MT the metal ion of 50% dissociate is respectively: Zn-MT:3.5 ~ 4.5; Cd-MT:2.5 ~ 3.5; Cu-MT<1.0.Because MT lacks die aromatischen Aminosaeuren, therefore at 280nm place without absorption peak, but there is the absorption peak relevant to metal.The MT of metal is gone to have an absorption peak at 190nm place.All MT is contained in all vertebratess, most plants and microbe.Be no matter that natural birth survives be the MT that induction produces, its amino acid composition is substantially identical, main difference is at institute's containing metal and content thereof.Current product mainly extracts from rabbit liver, horse kidney, pork liver and microorganism (as thick neurospora) etc.
About function and the exploitation of metallothionein(MT), successively held four International Workshop symposials altogether in Switzerland, Japan, the U.S. from 1978 to 1999, the 5th International Workshop symposial is held in October, 2005 in Beijing.Within 1987, MT is listed in [863] plan by China, and " eight or five ", " 95 " great brainstorm project, list national level [torch plan] for 1994 in; MT project in 2003 is classified as by the Ministry of Science and Technology that " national science and technology achievement key popularization plan project, nineteen ninety-five, MT was listed in the biological technology products recommended to countries in the world by United Nations.As can be seen here from domestic abroad to the great attention of the research of MT, exploitation, popularization, application.
Biological fermentation about MT albumen is produced, once the genetically engineered recombination method such as useful intestinal bacteria, Bacillus subtilus, suis, yeast, but all puts into production so far because expression amount is too low.
MT3 expresses in human animal's brain, and research finds that it can suppress axon growth, except it is combined with harmful heavy metals and anti-oxidant and except the function of neuroprotective tissue, may suppress the effect of the generation of the senile dementia of neurofibrillary tangles in addition.
Summary of the invention
In view of the defect of above expression amount deficiency, main purpose of the present invention be utilize artificial gene complete synthesis method by codon optimized, and expressor head and the tail tandem sequence repeats is become protokaryon (E.coli) expression vector comprising 4 copy MT3 cistrons for 4 times, in order to improve expression amount.
Improve a method for human metal thioalbumen MT3 prokaryotic expression carrier expression amount, comprise and the series connection unit of the coding region containing the human metal thioalbumen molecule MT3 after codon optimized is formed the Tandem repeat comprising 4 copy human metal thioalbumen MT3 cistrons 4 times at prokaryotic expression carrier clone district tandem sequence repeats; By the prokaryotic expression carrier transform both prokaryotic host cell containing Tandem repeat; Cultivate and this cell of amount reproduction, utilize inductor to lead human metal thioalbumen molecule MT3 and express.
The inventive method also can comprise the purification procedures of the human metal thioalbumen molecule MT3 after to induction further.These steps are by existing techniques in realizing.
Wherein, each described series connection unit preferably includes rrna land and the human metal thioalbumen molecule MT3 after codon optimized.
Each described series connection unit also preferably includes the restriction enzyme site being positioned at series connection unit two ends.
MT3 coding region sequence after codon optimized is preferably as shown in SEQIDNO.1.
Contain the tandem sequence repeats region sequence of the MT3 coding region after codon optimized as shown in SEQIDNO.7.
The coding gene sequence of the human metal thioalbumen molecule MT3 after codon optimized is as shown in SEQIDNO.1.
For improving a Tandem repeat for human metal thioalbumen MT3 prokaryotic expression amount, described Tandem repeat joins 4 times by unit repeated strings of connecting and forms; Described series connection unit comprises the coding region of rrna land and the human metal thioalbumen MT3 after codon optimized.
Any one in SEQIDNO.2 of described Tandem repeat sequence preference.
Express a prokaryotic expression carrier of human metal thioalbumen MT, described prokaryotic expression carrier contains Tandem repeat of the present invention.
The present invention has the following advantages:
1, the optimizing codon of described people MT3 albumen improves the availability of such password in intestinal bacteria.
2, in described MT3 prokaryotic expression carrier, MT3 expresses cistron and adds nearly 3 times, and the average expression amount of MT is increased to average 8.8% by 3.6% when singly copying, and expression amount adds 2.4 times;
3, the MT albumen that described MT3 prokaryotic expression carrier is expressed is natural unit molecule, and non pregnant women.
Accompanying drawing explanation
Fig. 1 is a kind of MT3 cascaded structure schematic diagram provided by the invention.
Explain: DNA sequence dna representative in schematic diagram is a part for constructed prokaryotic expression carrier, starts, terminate with " T7terminator " with " T7promoter "; " Lacoperator " is lacI binding site; " RBS " is ribosome binding sequence.The transcription termination signal sequence that " T7terminator " is T7 phage.
Embodiment
Below in conjunction with specific embodiment, technical scheme of the present invention is further described, but does not make limitation of the invention.
The technical scheme adopted is as follows:
First, the MT protein molecular of people MT3 totally four kinds of hypotypes is translated into cDNA sequence by the first step of the present invention, then through the codon of DNA2.0 software optimization MTcDNA, it is made to be more suitable for colibacillary codon preference, and composition optimizes is carried out to N-terminal initial 15 amino acid encoding region, avoid the formation of strong secondary structure, the MT3 coding region sequence after codon optimized is preferably as shown in SEQIDNO.1.
Second step is the full length sequence with oligonucleotide substep extension method synthesis MT3,5 ' end adds NcoI restriction enzyme site, 3 ' end adds SpeI---NheI two restriction enzyme sites successively, PCR primer is after NcoI/NheI double digestion purifying, be settled to 50ng/ul, again prokaryotic expression carrier pET28a (+) is cut purifying through NcoI/NheI enzyme, be settled to 100ng/ul.
3rd step, connects and transforms:
1300rpm, centrifugal 5s, mixing, more once centrifugal with method, room temperature leaves standstill connection 2 hours.
Whole 10ul transforms JM109 competence bacteria, and through leaving standstill 30m, heat shock 1m, after adding 1mlLB, after 1h is cultivated in 37 degree of concussions, centrifugal 4m (6000rpm, EP whizzer), abandons supernatant, suspended sediment, is spread evenly across on the soft agar plate containing kantlex, 37 degree of incubator incubated overnight.Next day transfers clone, and PCR identifies positive recombinants, and positive colony, after sequencing analysis is correct, obtains the clone comprising 1 copy MT3 cistron.
Then carrying out first time is connected in series:
Get correct clone 1 strain, do enzyme with two pipes respectively and cut: pipe-1 enzyme SpeI/BamHI is two to be cut, and reclaims large fragment (about 5.5kb) as carrier; Pipe-2 is cut with enzyme XbaI/BamHI is two, reclaims the fragment of 235bps.The recovery product of pipe connecting-1 and pipe-2, after qualification and DNA sequencing are analyzed, obtains the MT recombinant expression vector comprising 2 copy MT3 cistrons.
Second step is connected in series: adopt the first step to be connected in series product (comprising the correct clone of 2 copy MT cistrons): pipe-1 is cut with SpeI/XhoI enzyme, reclaims large fragment (carrier+2 copies MT cistron); Pipe-2 is cut with XbaI/XhoI enzyme, reclaims the DNA fragmentation (comprising 2 copy MT cistrons) of 537bps.Again after connecting qualification, the MT3 prokaryotic expression carrier of 4 copy MT3 cistrons can be obtained.
Shaking flask expression in a small amount:
Get recombinant expression plasmid conversion BL21 (DE3) expression strain of pET28a (+) empty carrier, the mono-copy of MT, 2 copies, 4 copies respectively, picking list bacterium colony inoculates 4ml2XYT substratum (containing 50ug/ml kantlex) respectively, 37 DEG C, 250rpm, concussion is cultivated, until bacterial growth is to logarithmic phase, add 0.4ulIPTG respectively to each pipe, 25 DEG C of inducing culture 6 hours.Collect 1ml bacterium liquid, centrifugation, PBS washes once, suspend with 500ulPBS again, sonicated cells, 12000rpm/15 minute, 4 DEG C centrifugal abandons precipitation, get supernatant loading 20%SDS-PAGE, through Xylene Brilliant Cyanine G colour developing, decolouring, gel imaging instrument calculates the ratio that target stripe accounts for total protein, result (as follows) display increases with copy number, and expression amount increases (according to target ribbon density accounts for total protein density percent than calculating).
Table 1. different MT3 copy number carrier target stripe density under shaking bacterium condition in a small amount accounts for total protein density percent ratio
Empty carrier | Singly copy plasmid | 2 copy plasmids | 4 copy plasmids | |
Density (%) before correcting | 4.2 | 7.8 | 9.9 | 15.0 |
Density (%) after correcting | 0 | 3.6 | 5.7 | 8.8 |
Claims (9)
1. improve a method for human metal thioalbumen MT3 prokaryotic expression carrier expression amount, it is characterized in that comprising the Tandem repeat series connection unit of the coding region containing the human metal thioalbumen molecule MT3 after codon optimized being comprised 4 copy human metal thioalbumen MT3 cistrons in 4 formation of prokaryotic expression carrier clone district tandem sequence repeats; By the prokaryotic expression carrier transform both prokaryotic host cell containing Tandem repeat; Cultivate and this cell of amount reproduction, utilize inductor to lead human metal thioalbumen molecule MT3 and express.
2. method according to claim 1, is characterized in that each described series connection unit comprises rrna land and the human metal thioalbumen molecule MT3 after codon optimized.
3. method according to claim 1, is characterized in that each described series connection unit also comprises the restriction enzyme site being positioned at series connection unit two ends.
4. method according to claim 1, is characterized in that the MT3 coding region sequence after codon optimized is as shown in SEQIDNO.1.
5. the method according to any one of Claims 1 to 4, is characterized in that the tandem sequence repeats region sequence of the MT3 coding region after codon optimized is as shown in SEQIDNO.2.
6. the coding gene sequence of the human metal thioalbumen MT3 after codon optimized, is characterized in that sequence is as shown in SEQIDNO.1.
7., for improving a Tandem repeat for human metal thioalbumen MT3 prokaryotic expression amount, it is characterized in that described Tandem repeat joins 4 times by unit repeated strings of connecting and forms; Described series connection unit comprises the coding region of rrna land and the human metal thioalbumen MT3 after codon optimized.
8. Tandem repeat according to claim 7, is characterized in that described tandem sequence repeats region sequence is as shown in SEQIDNO.2.
9. express a prokaryotic expression carrier of human metal thioalbumen MT3, it is characterized in that described prokaryotic expression carrier contains the Tandem repeat described in claim 9 or 10.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510703939.9A CN105238804A (en) | 2015-10-26 | 2015-10-26 | Method for improving expression quantity of human metallothionein MT3 prokaryotic expression vector |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510703939.9A CN105238804A (en) | 2015-10-26 | 2015-10-26 | Method for improving expression quantity of human metallothionein MT3 prokaryotic expression vector |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105238804A true CN105238804A (en) | 2016-01-13 |
Family
ID=55036623
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510703939.9A Pending CN105238804A (en) | 2015-10-26 | 2015-10-26 | Method for improving expression quantity of human metallothionein MT3 prokaryotic expression vector |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105238804A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102154359A (en) * | 2010-12-31 | 2011-08-17 | 中国药科大学 | New high-efficiency secretion and expression system of colibacillus and application thereof |
CN102747085A (en) * | 2011-04-22 | 2012-10-24 | 天津科技大学 | Multicopy enhance flavor peptide expressed gene construction and expression |
CN103898153A (en) * | 2012-12-28 | 2014-07-02 | 山东东兴生物科技股份有限公司 | Multi-copy metallothionein recombinant expression vector and method thereof for high-efficiency expression of metallothionein |
-
2015
- 2015-10-26 CN CN201510703939.9A patent/CN105238804A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102154359A (en) * | 2010-12-31 | 2011-08-17 | 中国药科大学 | New high-efficiency secretion and expression system of colibacillus and application thereof |
CN102747085A (en) * | 2011-04-22 | 2012-10-24 | 天津科技大学 | Multicopy enhance flavor peptide expressed gene construction and expression |
CN103898153A (en) * | 2012-12-28 | 2014-07-02 | 山东东兴生物科技股份有限公司 | Multi-copy metallothionein recombinant expression vector and method thereof for high-efficiency expression of metallothionein |
Non-Patent Citations (1)
Title |
---|
NP_005945.1: "metallothionein-3 [Homo sapiens]", 《GENBANK》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103146724B (en) | Reorganized mannase, genetically-engineered bacteria of recombined mannose and hydrolyzing preparation mannan oligosaccharide method | |
CN103614386A (en) | Halostachys caspica metallothionein gene as well as recombinant protein and application thereof | |
CN112920984A (en) | Construction is based on formic acid and CO2Method and application of growing recombinant strain | |
CN109082434A (en) | A kind of pichia vector and preparation method thereof and recombinant pichia yeast strain | |
CN113136349A (en) | Construction of pichia pastoris recombinant strain for efficiently expressing myoglobin/hemoglobin from different sources | |
CN109897857B (en) | Optimized human interleukin-2 gene and its expression method and application | |
CN115747187B (en) | Recombinase UvsX and expression gene and application thereof | |
CN111996195A (en) | Prokaryotic recombinant expression and purification method of procalcitonin mutant protein | |
CN105238804A (en) | Method for improving expression quantity of human metallothionein MT3 prokaryotic expression vector | |
CN111849848A (en) | Construction and application of a phage-resistant Escherichia coli chassis cell | |
CN105238802A (en) | Method for improving expression quantity of human metallothionein MT2a prokaryotic expression vector | |
CN105238803A (en) | Method for improving expression quantity of human metallothionein MT1b prokaryotic expression vector | |
CN104561063A (en) | cDNA fragment, high-efficiency expression recombinant plasmid and genetically engineered bacterium of bovine enterokinase and and expression method of genetically engineered bacterium | |
CN115785283A (en) | PAG-Tn5 mutant and application thereof | |
CN111944811B (en) | Double sgRNA for targeted knockout of FRZB gene, pig fibroblast line for knockout of FRZB gene and application of pig fibroblast line | |
CN105255929A (en) | Method for increasing expression quantity of human metallothionein (MT4) prokaryotic expression vector | |
CN115960193A (en) | Expression and application of female specific protein of cynoglossus semilaevis | |
CN114250241A (en) | One-step BsaI enzyme digestion connecting fragment assembling method, assembling kit and application | |
CN106591349A (en) | Chlamydomonas exogenous gene expression system based on blue light induction and application thereof | |
CN114774421B (en) | Zymomonas mobilis endogenous promoter mutant | |
CN111979166A (en) | Engineering bacterium for specifically removing arsenic as well as construction method and application thereof | |
CN105062906A (en) | Optimized organic phosphorus hydrolase yeast engineering bacteria and organic phosphorus hydrolase production | |
CN119220508B (en) | A deoxynivalenol-degrading enzyme and its encoding gene, preparation method and application | |
US20240270824A1 (en) | HEMOGLOBIN (Hb) RECOMBINANT EXPRESSION VECTOR AND RECOMBINANT ENGINEERING BACTERIUM, AND PREPARATION METHOD AND USE THEREOF | |
CN118620810A (en) | A strain of Bacillus subtilis tolerant to low pH and high urea concentration |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160113 |
|
RJ01 | Rejection of invention patent application after publication |